CE-SDS method development, validation and best practice - An overview

Research output: Contribution to JournalReview articleAcademicpeer-review

Abstract

CE-SDS has been implemented in the biopharmaceutical industry and is being used for the characterization of therapeutic proteins in most Biological License Applications currently submitted. An overview is presented on the separation mechanism, methodology and good working practices / best practices. The CE-SDS platform method development and validation are discussed and typical scientifically and regulatory issues and troubleshooting situations are highlighted. This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)2361-2374
Number of pages14
JournalElectrophoresis
Volume40
Issue number18-19
DOIs
Publication statusE-pub ahead of print - 29 May 2019

Bibliographical note

This article is protected by copyright. All rights reserved.

Keywords

  • Best practice
  • CE-SDS
  • Method development
  • Method validation
  • Platform methodology

Fingerprint Dive into the research topics of 'CE-SDS method development, validation and best practice - An overview'. Together they form a unique fingerprint.

Cite this